AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 80 filers reported holding AKERO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,800,193 | +134.2% | 35,591 | +77.1% | 0.00% | +33.3% |
Q1 2023 | $768,682 | -48.1% | 20,091 | -25.7% | 0.00% | -50.0% |
Q4 2022 | $1,481,573 | +44.3% | 27,036 | -32.1% | 0.01% | -25.0% |
Q4 2020 | $1,027,000 | +234.5% | 39,815 | +298.7% | 0.01% | +100.0% |
Q3 2020 | $307,000 | -18.4% | 9,985 | -33.8% | 0.00% | -33.3% |
Q2 2020 | $376,000 | -8.5% | 15,088 | -22.2% | 0.01% | -45.5% |
Q1 2020 | $411,000 | -68.4% | 19,398 | -66.8% | 0.01% | +37.5% |
Q4 2019 | $1,299,000 | +202.8% | 58,508 | +210.0% | 0.01% | +100.0% |
Q3 2019 | $429,000 | – | 18,874 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |